RecruitingNot ApplicableNCT07540312

A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome

A Prospective Interventional Trial With a Non-invasive Variable Compression System (VCS) to Determine the Efficacy in Patients With Moderate to Severe Irritable Bowel Syndrome (IBS)


Sponsor

PGP Health

Enrollment

20 participants

Start Date

May 21, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This prospective, interventional trial is intended to determine the safety and effectiveness of the Variable Compression System (VCS) device for Irritable Bowel Syndrome (IBS). This pilot study will enroll 20 subjects who will be required to wear the VCS device for a minimum of 6 hours a day and follow up at 21 days, 8 weeks, and 6 months post-device administration.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria3

  • Written informed consent to participate in the trial as prescribed.
  • Subjects with a weight of ≥50 kg and a body mass index between 18 and 40 kg/m2.
  • Diagnosed with IBS(C)-constipation, IBS(D)-diarrhea, or IBS(M)-mixed patients' diagnosis according to Rome Criteria (moderate to severe).

Exclusion Criteria8

  • Allergy to the investigational device or any components or clinically significant allergies (excluding mild seasonal allergies), in the opinion of the investigator.
  • Clinically relevant history of gastrointestinal, cardiovascular, musculoskeletal, endocrine, hematologic, psychiatric, renal, hepatic, bronchopulmonary, neurologic, immunologic, lipid metabolism disorders, or psychiatric disorders making implementation of the protocol or interpretation of the trial results difficult, or that would put the participant at risk by participating in the trial in the opinion of the Investigator.
  • Hospital admission or major surgery within 30 days prior to screening.
  • Pregnant, or positive urine pregnancy test.
  • Participation in any other investigational drug trial within 30 days prior to screening.
  • Participant with substance use disorder (SUD) and/or alcohol use disorder (AUD).
  • Participant who has other conditions that may affect compliance in the opinion of the investigator, or who are unable to participate in the trial on his/her own.
  • Participant with end stage organ disease.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEVariable Compression System

The VCS is a wearable device that provides compression of the lower abdomen, torso support, and covers the torso in Far Infrared Radiation (FIR).


Locations(3)

Central Florida Gastro Research

Kissimmee, Florida, United States

UChicago Medicine AdventHealth Medical Group Gastroenterology at Bolingbrook

Bolingbrook, Illinois, United States

Delta Gastroenterology PC

Southhaven, Mississippi, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07540312


Related Trials